-
A5032-500 mg
Thomas Scientific
Aromatase inhibitor that prevents adrenal steroid synthesis. It is used to treat breast cancer and Cushing’s disease. (C08-0488-805)
Price: $238.92List Price: $265.46D,L-Aminogluthethimide is an inhibitor of aromatase and adrenal steroid synthesis that exhibits immunosuppressive and anticancer chemotherapeutic activities. This compound is used to treat breast cancer and Cushing’s disease. -
A5032-1 g
Thomas Scientific
Aromatase inhibitor that prevents adrenal steroid synthesis. It is used to treat breast cancer and Cushing’s disease. (C08-0489-114)
Price: $341.47List Price: $379.41D,L-Aminogluthethimide is an inhibitor of aromatase and adrenal steroid synthesis that exhibits immunosuppressive and anticancer chemotherapeutic activities. This compound is used to treat breast cancer and Cushing’s disease. -
A5302-100 mg
Thomas Scientific
Aromatase inhibitor used to treat ER-positive breast cancer. It suppresses estrogen synthesis and induces apoptosis in breast cancer cells. (C08-0489-034)
Price: $302.20List Price: $335.78Anastrozole is a third generation aromatase inhibitor that suppresses synthesis of estrogen. Anastrozole exhibits anticancer chemotherapeutic activity and is clinically used to treat ER-positive breast cancer. -
A5302-250 mg
Thomas Scientific
Aromatase inhibitor used to treat ER-positive breast cancer. It suppresses estrogen synthesis and induces apoptosis in breast cancer cells. (C08-0489-396)
Price: $518.80List Price: $576.44Anastrozole is a third generation aromatase inhibitor that suppresses synthesis of estrogen. Anastrozole exhibits anticancer chemotherapeutic activity and is clinically used to treat ER-positive breast cancer. -
A5302-1 g
Thomas Scientific
Aromatase inhibitor used to treat ER-positive breast cancer. It suppresses estrogen synthesis and induces apoptosis in breast cancer cells. (C08-0489-826)
Price: $1,576.80List Price: $1,752.00Anastrozole is a third generation aromatase inhibitor that suppresses synthesis of estrogen. Anastrozole exhibits anticancer chemotherapeutic activity and is clinically used to treat ER-positive breast cancer. -
13321-1A selective inhibitor of matrix metalloproteinase-2 (MMP-2) demonstrating an IC50 value of 12 nM significantly less potent towards MMP-1, MMP-3, MMP-7, and MMP-9 (IC<sub>50</sub> = 50, 4.5, 50, and 2 µM, respectively) suppresses invasive
-
13321-10A selective inhibitor of matrix metalloproteinase-2 (MMP-2) demonstrating an IC50 value of 12 nM significantly less potent towards MMP-1, MMP-3, MMP-7, and MMP-9 (IC<sub>50</sub> = 50, 4.5, 50, and 2 µM, respectively) suppresses invasive
-
13321-5A selective inhibitor of matrix metalloproteinase-2 (MMP-2) demonstrating an IC50 value of 12 nM significantly less potent towards MMP-1, MMP-3, MMP-7, and MMP-9 (IC<sub>50</sub> = 50, 4.5, 50, and 2 µM, respectively) suppresses invasive
-
18506-1An aminopeptidase B inhibitor that is commonly used to characterize novel proteases.
-
18506-10An aminopeptidase B inhibitor that is commonly used to characterize novel proteases.
-
18506-5An aminopeptidase B inhibitor that is commonly used to characterize novel proteases.
-
11815-1A natural product which effectively kills both malarial parasites P. falciparum and P.